# Eton Pharmaceuticals, Inc.: filings

ETON · Nasdaq · CIK 1710340 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eton.md) · [Financials](/companies/eton/financials.md) · [Filings](/companies/eton/filings.md) · [Insiders](/companies/eton/insiders.md)

## Reports and events: 203 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 149, 4 112, 10-Q 24, 144 21, 3 15, SC 13G/A 9, 10-K 8, DEF 14A 8, UPLOAD 7, S-8 6, CORRESP 5, 424B5 4, 8-K/A 4, EFFECT 4, S-1/A 4, SC 13G 4, 4/A 3, S-3 3, 10-K/A 2, 424B3 2, D 2, DEFA14A 2, SC 13D/A 2, SCHEDULE 13G/A 2, 144/A 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, CT ORDER 1, DRS 1, DRS/A 1, FWP 1, NT 10-Q 1, S-1 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 11:15 ET | [8-K](/filings/0001437749-26-032600.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-26-032600 |
| 2026-09-28 | 11:15 ET | [8-K](/filings/0001437749-26-031281.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-031281 |
| 2026-08-13 | 20:16 ET | [10-Q](/filings/0001437749-26-027684.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027684 |
| 2026-08-13 | 20:10 ET | [8-K](/filings/0001437749-26-027672.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027672 |
| 2026-08-05 | 11:00 ET | [8-K](/filings/0001437749-26-025781.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-26-025781 |
| 2026-08-04 | 11:00 ET | [8-K](/filings/0001437749-26-025506.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-025506 |
| 2026-07-29 | 11:00 ET | [8-K](/filings/0001437749-26-024746.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-024746 |
| 2026-06-09 | 20:31 ET | [8-K](/filings/0001437749-26-020005.md) | 5.07 Shareholder vote results | 0001437749-26-020005 |
| 2026-05-19 | 20:45 ET | [8-K](/filings/0001437749-26-017799.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-26-017799 |
| 2026-05-14 | 20:17 ET | [10-Q](/filings/0001437749-26-017064.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017064 |
| 2026-05-14 | 20:16 ET | [8-K](/filings/0001437749-26-017063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-017063 |
| 2026-05-01 | 11:05 ET | [8-K](/filings/0001437749-26-014315.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-014315 |
| 2026-04-27 | 11:05 ET | [8-K](/filings/0001437749-26-013369.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-013369 |
| 2026-04-24 | 20:05 ET | [DEF 14A](/filings/0001437749-26-013313.md) | Proxy statement, period 2026-06-09 | 0001437749-26-013313 |
| 2026-04-16 | 11:05 ET | [8-K](/filings/0001437749-26-012488.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012488 |
| 2026-04-15 | 20:05 ET | [8-K](/filings/0001437749-26-012381.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-26-012381 |
| 2026-03-19 | 20:15 ET | [10-K](/filings/0001437749-26-009059.md) | Annual report, period 2025-12-31 | 0001437749-26-009059 |
| 2026-03-19 | 20:15 ET | [8-K](/filings/0001437749-26-009060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-009060 |
| 2026-03-02 | 12:00 ET | [8-K](/filings/0001437749-26-006209.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-26-006209 |
| 2026-02-25 | 19:18 ET | [8-K](/filings/0001437749-26-005537.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-005537 |
| 2026-02-02 | 12:00 ET | [8-K](/filings/0001437749-26-002605.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-002605 |
| 2025-12-04 | 12:30 ET | [8-K](/filings/0001437749-25-036853.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-036853 |
| 2025-11-18 | 21:16 ET | [8-K/A](/filings/0001437749-25-035597.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-25-035597 |
| 2025-11-06 | 21:28 ET | [10-Q](/filings/0001437749-25-033619.md) | Quarterly report, period 2025-09-30 | 0001437749-25-033619 |
| 2025-11-06 | 21:25 ET | [8-K](/filings/0001437749-25-033616.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033616 |
| 2025-08-07 | 20:23 ET | [10-Q](/filings/0001437749-25-025444.md) | Quarterly report, period 2025-06-30 | 0001437749-25-025444 |
| 2025-08-07 | 20:17 ET | [8-K](/filings/0001437749-25-025438.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025438 |
| 2025-07-08 | 11:10 ET | [8-K](/filings/0001437749-25-022298.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-022298 |
| 2025-06-27 | 11:10 ET | [8-K](/filings/0001437749-25-021383.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-021383 |
| 2025-06-20 | 20:17 ET | [8-K](/filings/0001437749-25-020916.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-25-020916 |
| 2025-06-10 | 20:17 ET | [8-K](/filings/0001437749-25-019983.md) | 5.07 Shareholder vote results | 0001437749-25-019983 |
| 2025-05-28 | 21:28 ET | [8-K](/filings/0001437749-25-018698.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-018698 |
| 2025-05-13 | 20:21 ET | [10-Q](/filings/0001437749-25-016475.md) | Quarterly report, period 2025-03-31 | 0001437749-25-016475 |
| 2025-05-13 | 20:16 ET | [8-K](/filings/0001437749-25-016468.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016468 |
| 2025-05-02 | 20:37 ET | [8-K/A](/filings/0001437749-25-014334.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events | 0001437749-25-014334 |
| 2025-04-28 | 11:15 ET | [8-K](/filings/0001437749-25-013227.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-013227 |
| 2025-04-25 | 20:16 ET | [DEF 14A](/filings/0001437749-25-013137.md) | Proxy statement, period 2025-06-10 | 0001437749-25-013137 |
| 2025-04-01 | 11:15 ET | [8-K](/filings/0001437749-25-010358.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-010358 |
| 2025-03-18 | 16:16 ET | [8-K](/filings/0001437749-25-008163.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-008163 |
| 2025-03-18 | 11:15 ET | [8-K](/filings/0001437749-25-008137.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-008137 |
| 2025-03-18 | 11:10 ET | [10-K](/filings/0001437749-25-008136.md) | Annual report, period 2024-12-31 | 0001437749-25-008136 |
| 2025-03-14 | 11:15 ET | [8-K](/filings/0001437749-25-007615.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-007615 |
| 2025-03-07 | 21:16 ET | [8-K/A](/filings/0001437749-25-006678.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events | 0001437749-25-006678 |
| 2025-03-03 | 12:15 ET | [8-K](/filings/0001437749-25-005799.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-005799 |
| 2025-02-07 | 12:15 ET | [8-K](/filings/0001437749-25-003070.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-003070 |
| 2025-02-06 | 11:55 ET | [8-K](/filings/0001437749-25-002935.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-002935 |
| 2025-01-03 | 12:05 ET | [8-K](/filings/0001437749-25-000109.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-25-000109 |
| 2024-12-20 | 12:05 ET | [8-K](/filings/0001437749-24-038020.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-24-038020 |
| 2024-12-17 | 12:05 ET | [8-K](/filings/0001437749-24-037689.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-037689 |
| 2024-12-12 | 21:30 ET | [8-K](/filings/0001437749-24-037367.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-24-037367 |

Page 1 of 5. [Older](/companies/eton/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.